Countermeasures and Mechanisms of Drug Resistance in Immunotherapy for Cervical Cancer
Cervical cancer has become a serious threat to women's health worldwide, advanced cervical cancer has limited treatment options. 5-year survival rate is less than 20%, which is a huge challenge for the gynecologic oncology community. Immunotherapy is one of the important treatment for patients...
Main Authors: | YANG Junyuan, CAI Hongbing |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2022-09-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0162 |
Similar Items
-
Immune Therapy Resistance and Immune Escape of Tumors
by: Barbara Seliger, et al.
Published: (2021-02-01) -
Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
by: Justyna Błach, et al.
Published: (2021-08-01) -
The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives
by: Robert J. Walsh, et al.
Published: (2021-09-01) -
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
by: Alexandre Perrier, et al.
Published: (2020-07-01) -
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
by: Masahiro Kagabu, et al.
Published: (2020-03-01)